Imipenem resistance in nonfermenters causing nosocomial urinary tract infections

Indian Journal of Medical Sciences

Volumn 57, Issue 7, 2003, Pages 294-299

  Taneja, N ^b   Maharwal, S ^b   Sharma, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ALCALIGENES; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTION; CROSS INFECTION; DRUG EFFECT; GRAM NEGATIVE AEROBIC RODS AND COCCI; HUMAN; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 0141685952     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fass RJ, Barnishan J, Solomon MC, Ayers LW. In vitro activities of quinolones, β-lactams, tobramycin and trimethoprim sulfamethoxzol against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother 1996;40X:1412-8.
2. Bergogne-Berezin E. Resistance of Acinetobacter spp to antimicrobials overview of clinical resistance patterns and therapeutic problems, In: Bergogne-Berezin E, ML Joly Guillous, KJ Towner, eds. Acinetobacter: microbiology, epidemiolo infections, management. New York: CRC Press; 1996. pp. 133-83.
3. Gales AC, Jones RN, Turnidge J, Rennie T, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns and molecular typing in the global SENTRY antimicrobial surveillance program 1997-1999. Clin Infect Dis 2001;32(Suppl2):S146-55.
4. Troillet N, Samore HM, Carmeli Y. Imipenem resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 1997;25:1094-8.
5. Gaynes RP, Culver DH. The National Nosocomial infections surveillance system. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10-4.
6. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multi drug-resistant Acinetobacter sp and Sfenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features and trends in the SENTRY antimicrobial surveillance program 1997-1999. Clin Infect Dis 2001;32(Suppl2):S104-12.
7. Weyant SR, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, et al. Identification of unusual pathogenic gram negative aerobic and facultative anaerobic bacteria, 2nd edn. Baltimore, Maryland, USA: The William & Wilkins Co; 1996.
8. Agarwal KC. Antibiotic sensitivity test by disc diffusion method. Ind J Pathol Microbiol 1974;17:149-59.
9. Ouinn PJ. Clinical problems posed by multiresistant nonfermenting gram- negative pathogens. Clin Infect Dis 1998;27(Suppl I):S117-24.
10. Meharwal SK, Taneja N, Sharma SK, Sharma M. Complicated nosocomial UTI caused by nonfermenters. Indian J Urol 2002;18:123-8.
11. Nicoletti G, Stefans S. Survey of antibiotic resistance in gram negative nonfermentative bacteria other than pseudomonas in Italy. J Chemother 1994;6:20-4.
12. Neu HC. Resistance of Pseudomonas aeruginosa to imipenem. Infect Control Hosp Epidemiol 1992;13:7-9.